[Skip to content]

Royal Brompton and Harefield NHS Foundation Trust
Our research
Search our Site
.
Samples being dispensed from a pipette

Overview and recent achievements

What we do

Research into cardiovascular and respiratory medicine is central to the Trust’s mission and our starting point is the needs of the patients we treat every day. By investigating the causes of their conditions and testing new ways of diagnosing and treating them, we have been responsible for many significant medical advances which have been taken up across the NHS and beyond.

 

Excellence in research

The Trust has an internationally renowned research reputation and is the leading NHS hospital in cardiovascular and respiratory research in England, the UK and arguably in Europe. The Trust is also the largest postgraduate specialist heart and lung centre in the UK.

 

The Trust is home to two National Institute for Health Research (NIHR) Biomedical Research Units; one for both our respiratory and cardiovascular research programmes. Both BRUs were successfully renewed in 2011. The BRUs provide the organisational vehicle for the Trust’s experimental research activities as well as state-of-the-art facilities and staffed core resources.

 

Many of our researchers are key opinion leaders in respiratory or cardiovascular medicine.


Our partners

Our principal academic partner is the National Heart & Lung Institute in the Faculty of Medicine, Imperial College.

 

In 2011 the Trust has also initiated a major new strategic initiative, the Institute of Cardiovascular Medicine and Science, with Liverpool Heart and Chest Hospital NHS Foundation Trust. Research is a major plank of the Institute’s activities.

 

Our research is funded from a wide range of sources including the UK research councils, charities, the European Union and the Department of Health. We also work closely with industry partners – pharmaceutical, medical device, diagnostic and biotechnology companies. 

 


R&D Operational Capability Statement (RDOCS)

Our R&D operational capability statement sets out the Trust’s commitment to R&D and the roles and responsibilities of those in the organisation delivering those commitments.   The document has been endorsed by the Trust Board.

 

 The statement provides an operational overview of the clinical services, facilities and resources available to support R&D and is intended to be shared with Networks, Industry, Researchers and Sponsors.  It is a tool aimed at improving collaboration and effectiveness in research activities.

 

 

An 'artificial heart' next to a battery of the same size for comparison

Royal Brompton

Sydney Street,
London SW3 6NP
Tel: +44 (0)20 7352 8121

Harefield